Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia
Conditions: Antiphospholipid Syndrome; Thrombocytopenia; Treatment Intervention: Drug: zanubrutinib Sponsor: Zhang Lei Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 20, 2022 Category: Research Source Type: clinical trials
Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome
Conditions: Antiphospholipid Syndrome; Venous Thromboembolism; Arterial Thromboembolism; Major Bleed Intervention: Sponsor: Cardioangiologisches Centrum Bethanien Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2022 Category: Research Source Type: clinical trials
Impact of Antiphospholipid Antibodies on Thrombin Generation During Sars-CoV2 Infection (TACIT2 Study)
Conditions: Antiphospholipid Syndrome; COVID-19 Intervention: Diagnostic Test: characterization of aPL Sponsor: Central Hospital, Nancy, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2021 Category: Research Source Type: clinical trials